JMJD6 is a tumorigenic factor and therapeutic target in neuroblastoma

- Wong, Matthew, Sun, Yuting, Xi, Zhichao, Milazzo, Giorgio, Poulos, Rebecca C., Bartenhagen, Christoph, Bell, Jessica L., Mayoh, Chelsea, Ho, Nicholas, Tee, Andrew E., Chen, Xiaoqiong, Li, Yang, Ciaccio, Roberto, Liu, Pei Y., Jiang, Chen C., Lan, Qing, Jayatilleke, Nisitha, Cheung, Belamy B., Haber, Michelle, Norris, Murray D., Zhang, Xu D., Marshall, GM, Wang, JY, Huettelmaier, S, Fischer, M, Wong, JWH, Xu, H, Perini, G, Dong, Q, George, RE, Liu, T

The long noncoding RNA lncNB1 promotes tumorigenesis by interacting with ribosomal protein RPL35.

- Liu, Pei Y., Tee, Andrew E., Milazzo, Giorgio, Hannan, Katherine M., Maag, Jesper, Mondal, Sujanna, Atmadibrata, Bernard, Bartonicek, Nenad, Peng, Hui, Ho, Nicholas, Mayoh, Chelsea, Ciaccio, Roberto, Sun, Yuting, Henderson, Michelle J., Gao, Jixuan, Everaert, Celine, Hulme, Amy J., Wong, Matthew, Lan, Qing, Cheung, Belamy B., Zhang, Xu D.

The histone methyltransferase DOT1L promotes neuroblastoma by regulating gene transcription

- Wong, Matthew, Tee, Andrew E. L., Liu, Pei Yan, Zhang, Xu Dong, Hüttelmaier, Stefan, Wong, Jason W. H., Wang, Jenny, Polly, Patsie, Perini, Giovanni, Scarlett, Christopher J., Liu, Tao, Milazzo, Giorgio, Bell, Jessica L., Poulos, Rebecca C., Atmadibrata, Bernard, Sun, Yuting, Jing, Duohui, Ho, Nicholas, Ling, Dora

The BET bromodomain inhibitor exerts the most potent synergistic anticancer effects with quinone-containing compounds and anti-microtubule drugs

- Liu, Pei Y., Sokolowski, Nicholas, Liu, Bing, Yang, Rui H., Guo, Xiang Y., Tee, Andrew E., Itoh, Ken, Wang, Jenny, Kavallaris, Maria, Haber, Michelle, Norris, Murray D., Cheung, Belamy B., Guo, Su T., Byrne, Jennifer A., Ziegler, David S., Marshall, Glenn M., Dinger, Marcel E., Codd, Rachel, Zhang, Xu D., Liu, Tao, Siddiqi, Faraz, Atmadibrata, Bernard, Telfer, Thomas J., Sun, Yuting, Zhang, Lihong, Yu, Denise, Mccarroll, Joshua